Project #2: OXIDANT STRESS AND ASCORBIC ACID PROCESSING IN DIABETES The objective of the Program Project is to investigate the role of oxidative and carbonyl stress in the pathogenesis of diabetic complications. In particular, this project (Project 2) seeks to test the hypothesis that the oxidative stress resulting from high glucose in tissue culture and the diabetic rat is, in contrast to the diabetic human, primarily transition metal and aldose reductase dependent. Furthermore, we hypothesize many of the drugs thought to act as aldose reductase inhibitors, anti-glycating agents, growth factors, NO synthase, PKC and other inhibitors have beneficial effects in the rat as transition metal chelators and/or antioxidants. We propose to test these hypotheses by using a very powerful probe for assessment of oxidative stress in vivo, i.e 6-deoxy-6- fluoro ascorbic acid (F-ascorbate) in conjunction with 750 MHz 19F- NMR-spectroscopy, while at the same time providing the first biochemical insight into ascorbate catabolism in vivo and its modulation by diabetes. 1. To determine the chemical nature and mechanism of formation of F- ascorbate degradation products formed in vitro in low and high glucose environment. 2: To determine how the metabolic pathways of F-ascorbate degradation in cells implicated in diabetic complications are influenced by high glucose environment, and 3. To determine how diabetes in the rat and the human affects ascorbate processing, and whether uncovered abnormalities predict development of diabetic complications in the rat and DCCT patient. Using this novel approach, we expect to clarify the critical question: Is the reason why a large number of drugs have been successful in the diabetic rat but have failed in the human due to normalization of oxidative stress that is specific to the diabetic rat and of such overwhelming intensity that it masks other mechanisms of diabetes induced complications in the human. If confirmed, this outcome would have a profound effect on the future development of anti-diabetic therapies based on the rat model of hyperglycemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK057733-03
Application #
6659258
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$94,628
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Alexander, Nathan S; Palczewska, Grazyna; Stremplewski, Patrycjusz et al. (2016) Image registration and averaging of low laser power two-photon fluorescence images of mouse retina. Biomed Opt Express 7:2671-91
Kern, Elizabeth F O; Erhard, Penny; Sun, Wanjie et al. (2010) Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). Am J Kidney Dis 55:824-34
Kern, Timothy S; Du, Yunpeng; Miller, Casey M et al. (2010) Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy. Am J Pathol 176:2550-8
Ozdemir, Aylin M; Hopfer, Ulrich; Rosca, Mariana V et al. (2008) Effects of advanced glycation end product modification on proximal tubule epithelial cell processing of albumin. Am J Nephrol 28:14-24
Kern, Timothy S (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007:95103
Lu, Liang; Erhard, Penny; Salomon, Robert G et al. (2007) Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial. Am J Kidney Dis 50:305-13
Kern, Timothy S; Miller, Casey M; Du, Yunpeng et al. (2007) Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 56:373-9
Staniszewska, Magdalena M; Nagaraj, Ram H (2006) Upregulation of glyoxalase I fails to normalize methylglyoxal levels: a possible mechanism for biochemical changes in diabetic mouse lenses. Mol Cell Biochem 288:29-36
Genuth, Saul; Sun, Wanjie; Cleary, Patricia et al. (2005) Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications p Diabetes 54:3103-11
Sell, David R; Biemel, Klaus M; Reihl, Oliver et al. (2005) Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem 280:12310-5

Showing the most recent 10 out of 32 publications